RayzeBio, Inc. 4 SEC Filings

Filed On	Filing
28 Feb 2024	Form 4: Viking Global Investors Lp, 10% owner and 7 others Disposed of 6,642,700 shares (Other Transaction)
28 Feb 2024	Form 4: Viking Global Investors Lp, 10% owner and 7 others Disposed of 6,642,700 shares (Other Transaction)
27 Feb 2024	Form 4: Oliger Christy J., Director Disposed of 114,579 Employee Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2024	Form 4: You Angie, Director Disposed of 114,579 Employee Stock Option (right to buy) (Disposition to Issuer)
27 Feb 2024	Form 4: Van Hauwermeiren Timothy, Director Disposed of 48,628 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2024	Form 4: Tagliaferri Mary, Director Disposed of 114,579 Employee Stock Option (right to buy) (Disposition to Issuer)
27 Feb 2024	Form 4: Heyman Richard A., Director Returned 367,446 shares to the issuer ($23M)
27 Feb 2024	Form 4: Larson Yi, Director Disposed of 114,579 Employee Stock Option (right to buy) (Disposition to Issuer)
27 Feb 2024	Form 4: Katabi Maha, Director Returned 2,419,528 shares to the issuer ($151M) · Disposed of 18,235 Stock Option (right to buy) (Disposition to Issuer)
27 Feb 2024	Form 4: Moran Susan, CHIEF MEDICAL OFFICER Returned 323,455 shares to the issuer ($20.2M) · Disposed of 497,076 Employee Stock Option (right to buy) (Disposition to Issuer)
27 Feb 2024	Form 4: Kush Arvind, CHIEF FINANCIAL OFFICER Returned 78,433 shares to the issuer ($4.9M) · Disposed of 301,745 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 313,777 Employee Stock Option (right to buy) (Disposition to Issuer)
27 Feb 2024	Form 4: Song Kenneth, Director Returned 1,622,968 shares to the issuer ($101M) · Disposed of 1,353,370 Employee Stock Option (right to buy) (Disposition to Issuer)
06 Feb 2024	Form 4: Moran Susan, CHIEF MEDICAL OFFICER Received 30,875 shares by exercise or conversion ($100K)
17 Nov 2023	Form 4: Kush Arvind, Chief Financial Officer Granted 164,000 Stock Option (right to buy)
17 Nov 2023	Form 4: Song Kenneth, Director Granted 480,000 Stock Option (right to buy)
17 Nov 2023	Form 4: Katabi Maha, Director Granted 18,235 Stock Option (right to buy)
17 Nov 2023	Form 4: Moran Susan, Chief Medical Officer Granted 164,000 Stock Option (right to buy)
01 Nov 2023	Form 4: Van Hauwermeiren Timothy, Director Granted 48,628 Stock Option (right to buy)
21 Sep 2023	Form 4: Redmile Group, Llc, 10% owner and 2 others Received 1,857,706 shares by conversion
21 Sep 2023	Form 4: Katabi Maha, Director Received 1,947,306 shares by conversion · Bought 472,222 shares ($8.5M)

Comments